Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ultragenyx Pharmaceutical Inc. buy Wells Fargo & Company

Ultragenyx Pharmaceutical Inc.
Start price
€22.06
20.08.26 / 50%
Target price
€39.38
20.08.27
Performance (%)
-1.68%
Price
€25.00
20.08.26
Summary
This prediction is currently active. With a performance of -1.68%, the BUY prediction for Ultragenyx Pharmaceutical Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 20.08.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this prediction
Performance without dividends (%)
Name 1w
Ultragenyx Pharmaceutical Inc. -1.68%
iShares Core DAX® -1.586%
iShares Nasdaq 100 -4.148%
iShares Nikkei 225® -6.302%
iShares S&P 500 -3.225%

Comments by Wells_Fargo___Compan for this prediction

In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -1.68%
Target price 39.381
Change
Ends at 20.08.27

Ultragenyx Pharmaceutical (RARE) had its price target raised by Wells Fargo & Company from $45.00 to $46.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat

Wells Fargo & Company 
0
Report Share
20.08.26

Stopped prediction by Wells_Fargo___Compan for Ultragenyx Pharmaceutical Inc.

buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€21.59
05.08.26
€39.01
05.08.27
0.46%
20.08.26

Wells Fargo & Company 
05.08.26 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€22.06
06.05.26
€40.10
06.05.27
-1.68%
20.08.26

Wells Fargo & Company 
06.05.26 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€17.00
30.12.25
€38.21
30.12.26
27.59%
20.08.26

Wells Fargo & Company 
30.12.25 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€29.20
20.10.25
€55.74
20.10.26
-25.72%
20.08.26

Wells Fargo & Company 
20.10.25 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€26.00
10.07.25
€55.35
10.07.26
12.42%
11.07.26

Wells Fargo & Company 
10.07.25 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€41.80
20.12.24
€84.54
20.12.25
-32.06%
21.12.25

Wells Fargo & Company 
20.12.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€46.20
02.08.24
€68.71
02.08.25
-46.75%
03.08.25

Wells Fargo & Company 
02.08.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€37.60
08.12.23
€66.97
08.12.24
23.94%
09.12.24

Wells Fargo & Company 
08.12.23 50%